ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Chunlin Ge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8772-5554; OpenAlex author ID A5064859528. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 2 papers

Papers 3

Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancreatic cancer. First author DOI 10.1007/s00428-018-2455-5 ↗
Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis. Last author DOI 10.1080/15384047.2018.1564566 ↗
A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway. Last author DOI 10.2147/ott.s130481 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jinnian Ge · 1 shared paper, 2019 · strength 0.20
- Paper Rab14 overexpression regulates gemcitabine sensitivity through regulation of Bcl-2 and mitochondrial function in pancre… DOI 10.1007/s00428-018-2455-5 ↗
Xuan Zhu · 1 shared paper, 2019 · strength 0.16
- Paper Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axi… DOI 10.1080/15384047.2018.1564566 ↗
Lei Zhao · 1 shared paper, 2017 · strength 0.07
- Paper A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via th… DOI 10.2147/ott.s130481 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.